Correlation Between Dogwood Therapeutics, and Virax Biolabs
Can any of the company-specific risk be diversified away by investing in both Dogwood Therapeutics, and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dogwood Therapeutics, and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dogwood Therapeutics, and Virax Biolabs Group, you can compare the effects of market volatilities on Dogwood Therapeutics, and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dogwood Therapeutics, with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dogwood Therapeutics, and Virax Biolabs.
Diversification Opportunities for Dogwood Therapeutics, and Virax Biolabs
0.4 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Dogwood and Virax is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Dogwood Therapeutics, and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and Dogwood Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dogwood Therapeutics, are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of Dogwood Therapeutics, i.e., Dogwood Therapeutics, and Virax Biolabs go up and down completely randomly.
Pair Corralation between Dogwood Therapeutics, and Virax Biolabs
Given the investment horizon of 90 days Dogwood Therapeutics, is expected to generate 0.81 times more return on investment than Virax Biolabs. However, Dogwood Therapeutics, is 1.23 times less risky than Virax Biolabs. It trades about 0.02 of its potential returns per unit of risk. Virax Biolabs Group is currently generating about 0.01 per unit of risk. If you would invest 698.00 in Dogwood Therapeutics, on September 2, 2024 and sell it today you would lose (458.00) from holding Dogwood Therapeutics, or give up 65.62% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dogwood Therapeutics, vs. Virax Biolabs Group
Performance |
| Timeline |
| Dogwood Therapeutics, |
| Virax Biolabs Group |
Dogwood Therapeutics, and Virax Biolabs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dogwood Therapeutics, and Virax Biolabs
The main advantage of trading using opposite Dogwood Therapeutics, and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dogwood Therapeutics, position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.| Dogwood Therapeutics, vs. Viracta Therapeutics | Dogwood Therapeutics, vs. Viking Therapeutics | Dogwood Therapeutics, vs. Dyadic International | Dogwood Therapeutics, vs. Surrozen Warrant |
| Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Neurobo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |